Patents Assigned to Aegis Technology, Inc.
  • Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
    Patent number: 5250286
    Abstract: A method of using an imidazoline compound, which is a vasodilator and an alpha-adrenergic blocking agent, for the treatment of symptoms of chronic obstructive pulmonary diseases (COPD), including cystic fibrosis, chronic bronchitis and emphysema, or COPD where it is associated with asthma, comprises administering the imidazoline to a patient by inhalation. Preferably, the imidazoline compound employed is tolazoline. The presentation of an imidazoline compound in a device for the administration of an aerosol is disclosed.
    Type: Grant
    Filed: November 27, 1991
    Date of Patent: October 5, 1993
    Assignee: Aegis Technology, Inc.
    Inventor: Alvaro H. Skupin
  • Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
    Patent number: 5096916
    Abstract: A method of using an imidazoline compound, which is a vasodilator and an alpha-adrenergic blocking agent, for the treatment of symptoms of chronic obstructive pulmonary diseases (COPD), including cystic fibrosis, chronic bronchitis and emphysema, or COPD where it is associated with asthma, comprises administering the imidazoline to a patient by inhalation. Preferably, the imidazoline compound employed is tolazoline. The presentation of an imidazoline compound in a device for the administration of an aerosol is disclosed.
    Type: Grant
    Filed: May 7, 1990
    Date of Patent: March 17, 1992
    Assignee: Aegis Technology, Inc.
    Inventor: Alvaro H. Skupin